Modulation of Toll-Like Receptor Signalling as a New Therapeutic Principle

• Philipp M. Lepper,
• Martha Triantafilou,
• Luke A. O'Neill,
• Natalija Novak,
• Hermann Wagner,
• Andrew E. Parker,
• Kathy Triantafilou

Affiliations

Philipp M. Lepper

Department of Internal Medicine V—Pneumology, Allergology and Respiratory Intensive Care Medicine, Saarland University Hospital, 66421 Homburg, Germany

Martha Triantafilou

Infection and Immunity Group, Department of Child Health, School of Medicine, University of Cardiff, University Hospital of Wales, Heath Park, Cardiff CF14 4XN, UK

Luke A. O'Neill

School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland

Natalija Novak

Department of Dermatology and Allergology, University of Bonn, 53012 Bonn, Germany

Hermann Wagner

Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, 80333 Munich, Germany

Andrew E. Parker

Institute of Molecular Medicine, Trinity Centre for Health Sciences, St. James' Hospital, Dublin 8, Ireland

Kathy Triantafilou

Infection and Immunity Group, Department of Child Health, School of Medicine, University of Cardiff, University Hospital of Wales, Heath Park, Cardiff CF14 4XN, UK